Insider Transactions in Q2 2019 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,240
+0.57%
|
$159,120
$13.78 P/Share
|
|
Jun 21
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
3,763
+0.18%
|
$52,682
$14.03 P/Share
|
|
Jun 20
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
15,400
+0.72%
|
$200,200
$13.86 P/Share
|
|
Jun 19
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
15,214
+0.72%
|
$197,782
$13.91 P/Share
|
|
Jun 14
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
10,760
+0.52%
|
$150,640
$14.0 P/Share
|
|
Jun 13
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
11,500
+0.55%
|
$161,000
$14.13 P/Share
|
|
Jun 12
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
7,500
+0.36%
|
$105,000
$14.0 P/Share
|
|
Jun 11
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
10,900
+0.53%
|
$141,700
$13.83 P/Share
|
|
Jun 07
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.61%
|
$163,800
$13.66 P/Share
|
|
Jun 06
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.62%
|
$163,800
$13.4 P/Share
|
|
Jun 04
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.62%
|
$163,800
$13.39 P/Share
|
|
May 20
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
50,000
+2.44%
|
$650,000
$13.5 P/Share
|
|
May 10
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
17,923
+0.91%
|
$232,999
$13.85 P/Share
|
|
May 07
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
57,000
+2.87%
|
$798,000
$14.1 P/Share
|
|
Apr 08
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
1,890,000
+50.0%
|
$30,240,000
$16.0 P/Share
|
|
Apr 08
2019
|
Column Group L P Director |
BUY
Conversion of derivative security
|
Direct |
13,093,134
+49.11%
|
-
|
|
Apr 08
2019
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,121,683
+24.14%
|
$65,946,928
$16.0 P/Share
|
|
Apr 08
2019
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
8,833,333
+50.0%
|
-
|